| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/29/2006 | US7098214 Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098211 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| 08/29/2006 | US7098210 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 08/29/2006 | US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens |
| 08/29/2006 | US7098208 Inhibitors of Akt activity |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098206 Psychological disorders; antidepressants; |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7098203 and selective serotonin reuptake inhibitors; 4-benzyloxymethyl-4-phenylazepanes; antidepressants; anxiety |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase |
| 08/29/2006 | US7098200 Analgesics |
| 08/29/2006 | US7098199 Administering a polycyclic sulfamate ester that is replaced with a sulfate group and incubated with a seroid sulphatase enzyme at 7.4 pH and 37 degrees C to provide a Km value of < 50 micrometers |
| 08/29/2006 | US7098198 Administering ezetimibe, a glucuronide of ezetimibe, SCH 48461 or SCH 58053 as cholesterol absorption inhibitors; antitumor agents for the prostate, breasts, endometrium, and colon; can be coadministered with another anticarcinogenic agent |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098196 Regulators of the hedgehog pathway, compositions and uses related thereto |
| 08/29/2006 | US7098195 Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells |
| 08/29/2006 | US7098194 Composition and method to homogeneously modify or cross-link chitosan under neutral conditions |
| 08/29/2006 | US7098193 Useful for the treatment of gastrointestinal conditions |
| 08/29/2006 | US7098192 Antisense oligonucleotide modulation of STAT3 expression |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098189 Wound and skin care compositions |
| 08/29/2006 | US7098188 Alkali and alkaline earth metal salts of topiramate |
| 08/29/2006 | US7098012 DNA demethylase, therapeutic and diagnostic uses thereof |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7097998 Aβ42 lowering agents |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097984 Binding receptors to oocytes; contraceptives |
| 08/29/2006 | US7097864 topical or transdermal anlgesics comprising extracts from shrubs and herbs, glutamine and fat soluble ascorbyl palmitate in the form of vitamin c; antiinflammatory agents |
| 08/29/2006 | US7097862 Methods of inhibiting tumor necrosis factor |
| 08/29/2006 | US7097860 Administering solution containing magnesium, or compound thereof |
| 08/29/2006 | US7097859 Indium supplement compositions and methods therefor |
| 08/29/2006 | US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms |
| 08/29/2006 | US7097849 Injectable aqueous dispersions of propofol |
| 08/29/2006 | US7097848 Comprising clothianidin and one or more insecticides selected from abamectin, emamectin or emamectin benzoate, and methiocarb; use smaller amounts; applying on plants, crops in agricultures |
| 08/29/2006 | US7097847 Process to prepare a skin softening composition |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | US7097831 α-Amylase-resistant starch for producing foodstuff and medicaments |
| 08/29/2006 | US7097828 Waterproofing; mixture containing thickener, emulsifers |
| 08/29/2006 | US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments |
| 08/29/2006 | US7097825 Methods and reagents to acquire MRI signals and images |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | US7097785 improving the hand or feel of the fabric; good oil repellency |
| 08/29/2006 | CA2521980C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2521958C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-pheyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2373410C A2a receptor agonists |
| 08/29/2006 | CA2342390C Sustained release ranolazine formulations |
| 08/29/2006 | CA2342340C New sustained release oral formulations |
| 08/29/2006 | CA2281684C Inhibition of cell-cell binding by lipid assemblies |
| 08/29/2006 | CA2280905C Highly lipophilic camptothecin derivatives |
| 08/29/2006 | CA2277914C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide |
| 08/29/2006 | CA2277891C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 08/29/2006 | CA2277890C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 08/29/2006 | CA2271306C Pharmaceutical suspension systems |
| 08/29/2006 | CA2271166C Compositions and uses thereof |
| 08/29/2006 | CA2270177C Transdermal administration of ment |
| 08/29/2006 | CA2268195C Azaheterocyclylmethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one |
| 08/29/2006 | CA2258152C Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 08/29/2006 | CA2255615C Compositions comprising conjugates of cis-docosahexaenoic acid and docetaxel |
| 08/29/2006 | CA2255564C Aerodynamically light particles for pulmonary drug delivery |
| 08/29/2006 | CA2247198C Topical pharmaceutical composition containing heparin |
| 08/29/2006 | CA2240735C Process for production of piperidine derivatives |
| 08/29/2006 | CA2240201C Process for the preparation of felodipine |
| 08/29/2006 | CA2238845C Novel 2,3,5-trimethyl-4-hydroxy anilide derivatives, preparation thereof and therapeutical use thereof |
| 08/29/2006 | CA2233677C A novel combination of a .beta.-receptor blocker and an opioid |
| 08/29/2006 | CA2213996C Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/29/2006 | CA2164842C Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2111836C Spin-trapping pharmaceutical compositions and methods for use thereof |
| 08/25/2006 | CA2534927A1 Use of active compounds for the prophylaxis and treatment of parasitic infections in fish |
| 08/24/2006 | WO2006089311A1 Vanilloid receptor ligands and their use in treatments |
| 08/24/2006 | WO2006089301A2 Diaminophenothiazine compositions and uses thereof |
| 08/24/2006 | WO2006089298A2 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 08/24/2006 | WO2006089290A1 Combinations and modes of administration of therapeutic agents and combination therapy |
| 08/24/2006 | WO2006089286A2 Triazadibenzoazulene compounds useful for the treatment and prevention of pain and screening methods therefor compounds useful for the treatment and prevention of pain and screening methods therefor |
| 08/24/2006 | WO2006089276A2 Pharmacokinetically improved compounds |
| 08/24/2006 | WO2006089275A2 Methods of making pharmacokinetically improved compounds comprising functional residues or groups and pharmaceutical compositions comprising said compounds |
| 08/24/2006 | WO2006089225A1 5- [4- (4- (2 -amino- 2 -methoxycarbonylethyl) phenoxy) benzilidene] thiazolidin-2 , 4-dion e derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma |
| 08/24/2006 | WO2006089221A2 Compounds inhibiting the aggregation of superoxide dismutase-1 |
| 08/24/2006 | WO2006089215A2 Pharmaceutical compositions and methods |
| 08/24/2006 | WO2006089211A2 Combat/training antioxidant micronutrient formulation and method of administration |
| 08/24/2006 | WO2006089177A2 Isoxazole combretastin derivatives for the treatment of disorders |
| 08/24/2006 | WO2006089168A2 Methods for modulating ion channels |
| 08/24/2006 | WO2006089167A1 Glucosamine materials |
| 08/24/2006 | WO2006089164A1 Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis |
| 08/24/2006 | WO2006089150A2 Antiangiogenic agents with aldesleukin |
| 08/24/2006 | WO2006089130A1 Kappa opioid receptor ligands |
| 08/24/2006 | WO2006089100A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/24/2006 | WO2006089076A2 Thiazole amides, imidazole amides and related analogues |
| 08/24/2006 | WO2006089070A2 Acne gel |
| 08/24/2006 | WO2006089066A1 Combinations therapy for treatment of demyelinating conditions |
| 08/24/2006 | WO2006089064A1 Methods for treating lymphomas using a combination of a chemotherapeutic agent and il-2 and optionally an anti-cd20 antibody |